Clinical Trial

A Randomized Clinical Trial to Evaluate the Effectiveness of Oral Potassium Citrate in Preventing Ureteral Stent Encrustation in Patients Undergoing Ureteroscopy for Uric Acid Kidney Stones

Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This randomized clinical trial aims to evaluate the efficacy of oral potassium citrate in reducing ureteral stent encrustation following ureteroscopy for uric acid kidney stones. The study will assess whether potassium citrate, by raising urinary pH, can prevent encrustation on stents, potentially improving patient outcomes and reducing complications.
Trial Details
NCT Number NCT06819553
Lead Sponsor Zagazig University
Conditions Urolithiasis, Stone Ureter
Enrollment 48 participants
Start Date 2024-11-03
Primary Completion 2025-02-01 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-11